Rapid advance pushes Twist Bioscience stock to $85.90 on bullish momentum and overbought signals

Traders Union
All News
Companies
Twist Bioscience gains 3.66% today

Highlights

TWST continues its sharp rally, up 13% over the past week and closing near the session high at $85.90.
Strong bullish momentum persists across all timeframes, but overbought indicators signal increased risk of a short-term pullback or volatility.
Expected trading range for the coming week is $84.00 to $90.00 with minor downside risk toward $82.00 support if momentum wanes.

Bullish momentum sustained as price anchors above major support levels

TWST is trading at $85.90, well above the MA-20 ($69.91), MA-50 ($61.73), and MA-200 ($42.88), signaling firm bullish momentum across short, medium, and long-term trends. The Ichimoku Kijun on D1 sits at $68.19 and serves as immediate support, while near-term support is at MA-20 ($69.91) and key support is at MA-50 ($61.73); near-term resistance comes into play at today’s high ($86.59), with the MA-5 cluster as secondary resistance.

Overbought signals intensify despite persistent weekly price surge

Momentum indicators on D1 remain broadly positive, with MACD and ADX both in strong buy territory. However, overbought signals are apparent as D1 RSI reads 71.04, Stoch RSI is at 75.25 (strong sell), and CCI is elevated at 167.90, suggesting upside may be stretched. BBP and AO point to continued buyer domination intraday, reinforcing the prevailing uptrend. TWST has surged $9.73 (13.03%) over the past week from a prev_week_close of $76.17, now sitting at the very top of the weekly range. Weekly volatility stands at 17.66%, and current price action reflects a rapid advance to fresh highs with little consolidation. In today’s session, the stock climbed 3.66%, underscoring ongoing bullish momentum.

Upside favored as bullish signals outweigh pullback risk near recent highs

For the coming week, TWST is expected to trade in a range between $84.00 and $90.00, keeping the action close to the recent high and far above the 52-week low of $23.30. W1 indicators—RSI, ADX, MACD, and MA-50—all display bullish signals, indicating a very high probability (more than 80%) of price appreciation, with a decline appearing much less likely. The baseline scenario sees consolidation inside this corridor. A bullish breakout could lift the price past $90.00 towards the annual high, while a bearish scenario sees a retreat towards the $84.00–$82.00 support cluster. The overall trend remains positive, but the overbought D1 oscillators signal increased risk of short-term pullback or volatility.

Loading...

The tweet was deleted by the author.

But we saved everything 🙂.

Earlier, analysts noted that Twist Bioscience was exhibiting sustained bullish momentum, with technical signals favoring further consolidation after notable gains. This article adds a new dimension by examining how evolving market dynamics may influence the prevailing trends, with traders advised to monitor for shifts in momentum as a signal for renewed upside or the emergence of reversal risk.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.